National drug pricing authority is in talks with the Insurance Regulatory and Development Authority


National News:

With reports of several hospitals seeking tsupreme-courto beat the price cap on stents by shifting charges under other heads, the National Paramacutical Pricing Authority (NPPA) plans to seek billing data from the insurance regulator and insurance providers to ensure price reductions are passed on to patients.

The national drug pricing authority is in talks with the Insurance Regulatory and Development Authority of India seeking information on billing so that the data can be analysed to detect circumvention of the price caps.



Latest Tweets

    Message: Invalid or expired token., Please check your Twitter Authentication Data or internet connection.